- The Impact of COVID-19 Regulations on Adherence to Recombinant Human Growth Hormone Therapy: Evidence from Real-World Data
- Use of machine learning to identify patients at risk of sub‑optimal adherence: study based on real‑world data from 10,929 children using a connected auto‑injector device
- Integrated Digital Health Solutions in the Management of Growth Disorders in Pediatric Patients Receiving Growth Hormone Therapy: A Retrospective Analysis